Transgenomic announces John Thompson to its Board of Directors
– USA, NE – Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced the appointment of John D.…